Drug Trial Radar · NCT05267470
A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)
Last checked: Nov 19, 2026Latest source record: Mar 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
74
Actual
Start
Mar 29, 2022
Primary completion
May 28, 2024
Study completion May 28, 2024
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this study are to evaluate the safety and tolerability of bemarituzumab monotherapy and combination with other anti-cancer therapies, and to determine the recommended phase 3 dose of bemarituzumab in combination with other anti-cancer therapies.
Conditions
- Squamous-Cell Non-Small-Cell Lung Cancer
Interventions
BemarituzumabDrug
Intravenous (IV) infusion
DocetaxelDrug
IV infusion
PembrolizumabDrug
IV infusion
CarboplatinDrug
IV infusion
PaclitaxelDrug
IV infusion
Nab-paclitaxelDrug
IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experienced a Dose Limiting Toxicity (DLT): Parts 1 and 4Time frame: Day 1 to Day 21 of Cycle 1 (each cycle was 21 days)
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 of cycle 1 to 100 days after the last dose of study treatment or end of study date, whichever occurred earlier (Parts 1, 2, and 4 cycle length = 21 days; Part 3 cycle length = 14 days). Median treatment duration was 6.2 weeks.
Locations
39 sites in 8 countries. Site status is shown where the registry gives one.
University of California Irvine
Orange, California
Morristown Medical Center
Morristown, New Jersey
Montefiore Einstein Center for Cancer Care
The Bronx, New York
University of Pittsburgh, Cancer Institute
Pittsburgh, Pennsylvania
Cliniques Universitaires Saint Luc
Brussels, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Belgium
Institut Bergonie
Bordeaux, France
CHU de Lyon - Hopital Louis Pradel
Bron, France
Hôpital Tenon
Paris, France
Centre Hospitalier Universitaire de Poitiers - Hopital la Miletrie
Poitiers, France
Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou
Rennes, France
Institut Gustave Roussy
Villejuif, France
National Cancer Center Hospital East
Kashiwa-shi, Chiba, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka, Japan
Wakayama Medical University Hospital
Wakayama, Wakayama, Japan
Przychodnia Lekarska Komed Roman Karaszewski
Konin, Poland
Pratia Mcm Krakow
Krakow, Poland
Krakowskie Centrum Medyczne Sp zoo
Krakow, Poland
Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
Instytut Genetyki i Immunologii GENIM Spzoo
Lublin, Poland
Centrum Medyczne Hope Clinic Sebastian Szklener
Lublin, Poland
Mazowieckie centrum leczenia
Otwock, Poland
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Severance Hospital Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Hospital Universitario Ramon y Cajal
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Hospital Regional Universitario de Malaga
Málaga, Andalusia, Spain
Hospital Universitario Virgen del Rocio
Seville, Andalusia, Spain
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, Spain
Hospital Clinic i Provincial de Barcelona
Barcelona, Catalonia, Spain
Institut Catala d Oncologia Hospitalet. Hospital Duran i Reynals
L'Hospitalet de Llobregat, Catalonia, Spain
Complexo Hospitalario Universitario A Coruña Hospital Teresa Herrera
A Coruña, Galicia, Spain
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Spain
National Cheng Kung University Hospital
Tainan, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation
Taoyuan, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.